comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 01:50:04 - browse：42

Business standing in the middle of a maze near a bag with a dollar sign on it. -- biotech coverage from STAT — Adobe

Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists.

Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself. These types of conditions aren’t unheard of, but have become more frequent as venture capitalists have a harder time raising funds, and as outside investors feel empowered to ask for more bang for their buck.

“A lot is changing in venture fundraising right now,” said Nan Li, co-founder and managing partner of Dimension, which launched last January. Outside investors tried to ask for a piece of Dimension, but the new firm had more than enough interest in its first fund and was able to turn down those proposals. Two other young VC firms told STAT they’ve fielded similar requests, and one investment group reported that it had managed to negotiate an equity stake in a VC firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Timeline: How the deadly wildfires took over Maui day by day

WSS

Flu, Covid vaccination rates decline, new survey data show

Indictment alleges Trump's ex

Treatments for cramps don't cut it. Why aren't there better options?

Medicare innovation center doesn’t save money, experts say

Illinois Supreme Court finds assault weapons ban constitutional

CDC picks Alphabet's Verily for wasterwater surveillance contract

entertainment

comprehensive

focus

Alkermes shareholders re

The Karikó problem: Lessons for funding basic research

Tori Bowie and the unacceptable rates of Black maternal death

Biogen’s boardroom scandal saddles CEO with first crisis

How one medical school became remarkably diverse

Maui wildfire now ranks as the fifth

DIEP, the 'gold standard' of breast reconstruction, is under threat

Study points to new risk in gene therapy death of Terry Horgan

Medical records are filled with copy

Patients, digital health players weigh in on FTC's data privacy plan

hotspot

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Dozens dead from Maui wildfires: What we know about the victims

Montana youths win climate lawsuit against state for promoting fossil fuels

European officials brace for rough respiratory virus season

The stability of $0 premiums in Medicare Advantage

Health insurers' Q3 question: how much care are people getting?

focus

entertainment

focus

Wikipedia